© 2025 MJH Life Sciences™ , Patient Care Online – Primary Care News and Clinical Resources. All rights reserved.
Eingun James Song, MD, FAAD
Articles
Real Cases, Key Takeaways: Applying Atopic Dermatitis Insights in Clinical Practice
June 09, 2025
Panelist discusses how patient cases demonstrate the importance of considering nonsteroidal agents in patients of color (due to hypopigmentation risks) and elderly patients (due to skin thinning), concluding that effective atopic dermatitis management requires proper moisturizing, appropriate corticosteroid cycling, and proactive twice-weekly maintenance with newer nonsteroidal topicals to prevent long-term complications.
Stronger Together: Collaborating With Dermatologists for Better Outcomes
June 09, 2025
Panelist discusses how referral to dermatology should occur when patients fail to reach treatment goals despite proper skincare, appropriate topical steroid and nonsteroid use, and proactive treatment, emphasizing the importance of maintaining open dialogue about systemic therapy options rather than dismissing them as “last resort” treatments.
Tailoring Treatment: Personalizing Topical Therapy for Patients With Atopic Dermatitis
June 09, 2025
Panelist discusses how topical treatment selection should be based on affected body areas, patient preferences for vehicle type, and disease extent, noting that patients prefer topical over systemic therapies and emphasizing the importance of using specialty pharmacies with manufacturer contracts to ensure affordable access through proper prior authorization processes.
Beyond Steroids: Clinical Trial Results on the Next Generation Agents for Atopic Dermatitis
June 09, 2025
nonsteroidal topicals including roflumilast (next-generation PDE4 inhibitor), ruxolitinib (JAK1/2 inhibitor), and tapinarof (aryl hydrocarbon receptor agonist) offer significant improvements in efficacy and tolerability compared with older agents like crisaborole, with clinical trial data showing 30% to 50% of patients achieving complete or near-complete clearance.
Topical Steroids and Topical Corticosteroids: Benefits, Risks, and Real-World Uses for Atopic Dermatitis
June 09, 2025
Panelist discusses how polling results show varied approaches to second-line atopic dermatitis treatment, emphasizing that topical corticosteroids remain the workforce but require proper usage limits of 1 to 2 weeks to avoid serious adverse effects, while highlighting growing patient concerns about steroid phobia and topical steroid withdrawal syndrome.
The Topical Toolbox: A Review of Atopic Dermatitis Treatment Options
June 09, 2025
Panelist discusses how the current treatment guidelines include 4 classes of topical therapies, with newer nonsteroidal options like JAK inhibitors and PDE4 inhibitors providing effective alternatives to long-term corticosteroid use.
Soothing the Skin: Wellness Practices for Atopic Dermatitis Management
June 09, 2025
Panelist discusses how proper skin care forms the foundation of atopic dermatitis treatment and emphasizes the importance of proactive rather than reactive treatment approaches using maintenance therapy.
Quantifying Atopic Dermatitis in Practice: Evaluating Patient Disease Severity
June 09, 2025
Panelist discusses how to assess atopic dermatitis severity using practical measures like body surface area, itch scores, and quality of life impact rather than complex clinical trial scoring systems.
A Practical Guide to Atopic Dermatitis Differential Diagnosis
June 09, 2025
Panelist discusses how atopic dermatitis presentation varies by age and skin tone, emphasizing that it’s a systemic condition with multiple comorbidities that can be prevented through early aggressive treatment.
Recognizing and Diagnosing Atopic Dermatitis With Confidence
June 09, 2025
Panelist discusses how the atopic dermatitis treatment landscape has evolved with new nonsteroidal topical therapies that can match the effectiveness of corticosteroids without their associated adverse effects and long-term risks.